Standard BioTools Inc. Stock-Based Compensation
Standard BioTools Inc. (LAB) reported Stock-Based Compensation of $12.87 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.
Financial Statements › Cash Flow › Operating Activities
us-gaap:ShareBasedCompensation · last filed 2026-08-05
- Standard BioTools Inc. share-based payment arrangement, noncash expense for the quarter ending 2026-06-30 was $4.05M, a 36.59% decline year-over-year.
- Standard BioTools Inc. share-based payment arrangement, noncash expense for the quarter ending 2026-03-31 was $8.82M, a 2.05% decline year-over-year.
- Standard BioTools Inc. share-based payment arrangement, noncash expense for the quarter ending 2025-12-31 was $5.74M, a 23.12% decline year-over-year.
- Standard BioTools Inc. share-based payment arrangement, noncash expense for the quarter ending 2025-09-30 was $8.47M, a 43.12% increase year-over-year.
- Standard BioTools Inc. share-based payment arrangement, noncash expense for fiscal 2025 was $29.61M, a 6.68% decline from fiscal 2024.
- Standard BioTools Inc. share-based payment arrangement, noncash expense for fiscal 2024 was $31.73M, a 141.80% increase from fiscal 2023.
- Standard BioTools Inc. share-based payment arrangement, noncash expense for fiscal 2023 was $13.12M, a 11.81% decline from fiscal 2022.
- Standard BioTools Inc. share-based payment arrangement, noncash expense for fiscal 2022 was $14.88M, a 7.58% decline from fiscal 2021.
| Period end | Share-based Payment Arrangement, Noncash Expense 3 month | Share-based Payment Arrangement, Noncash Expense 6 month | Share-based Payment Arrangement, Noncash Expense 9 month | Share-based Payment Arrangement, Noncash Expense 12 month |
|---|---|---|---|---|
| 2026-06-30 | $4.05M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $12.87M 10-Q · filed 2026-08-05 | $18.62M derived: sum of 3 quarters · filed 2026-08-05 | $27.09M derived: sum of 4 quarters · filed 2026-08-05 |
| 2026-03-31 | $8.82M 10-Q · filed 2026-05-06 | $14.57M derived: sum of 2 quarters · filed 2026-05-06 | $23.04M derived: sum of 3 quarters · filed 2026-05-06 | $29.43M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-12-31 | $5.74M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16 | $14.22M derived: sum of 2 quarters · filed 2026-03-16 | $20.60M derived: sum of 3 quarters · filed 2026-08-05 | $29.61M 10-K · filed 2026-03-16 |
| 2025-09-30 | $8.47M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | $14.86M derived: sum of 2 quarters · filed 2026-08-05 | $23.87M 10-Q · filed 2025-11-04 | $31.34M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-06-30 | $6.39M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-05 | $15.40M 10-Q · filed 2026-08-05 | $22.87M derived: sum of 3 quarters · filed 2026-08-05 | $28.79M derived: sum of 4 quarters · filed 2026-08-05 |
| 2025-03-31 | $9.01M 10-Q · filed 2026-05-06 | $16.48M derived: sum of 2 quarters · filed 2026-05-06 | $22.40M derived: sum of 3 quarters · filed 2026-05-06 | $29.13M derived: sum of 4 quarters · filed 2026-05-06 |
| 2024-12-31 | $7.47M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16 | $13.39M derived: sum of 2 quarters · filed 2026-03-16 | $20.12M derived: sum of 3 quarters · filed 2026-03-16 | $31.73M 10-K · filed 2026-03-16 |
| 2024-09-30 | $5.92M derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-04 | $12.65M derived: sum of 2 quarters · filed 2025-11-04 | $24.26M 10-Q · filed 2025-11-04 | $27.74M derived: sum of 4 quarters · filed 2026-03-16 |
| 2024-06-30 | $6.73M derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-15 | $18.34M 10-Q · filed 2025-08-15 | $21.82M derived: sum of 3 quarters · filed 2026-03-16 | $25.20M derived: sum of 4 quarters · filed 2026-03-16 |
| 2024-03-31 | $11.61M 10-Q · filed 2025-05-06 | $15.09M derived: sum of 2 quarters · filed 2026-03-16 | $18.47M derived: sum of 3 quarters · filed 2026-03-16 | $21.59M derived: sum of 4 quarters · filed 2026-03-16 |
| 2023-12-31 | $3.48M derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-16 | $6.86M derived: sum of 2 quarters · filed 2026-03-16 | $9.97M derived: sum of 3 quarters · filed 2026-03-16 | $13.12M 10-K · filed 2026-03-16 |
| 2023-09-30 | $3.39M derived: 10-Q 9 month − 10-Q 6 month · filed 2024-11-06 | $6.50M derived: sum of 2 quarters · filed 2024-11-06 | $9.65M 10-Q · filed 2024-11-06 | $11.33M derived: sum of 4 quarters · filed 2025-03-11 |
| 2023-06-30 | $3.11M derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-06 | $6.26M 10-Q · filed 2024-08-06 | $7.94M derived: sum of 3 quarters · filed 2025-03-11 | $12.44M derived: sum of 4 quarters · filed 2025-03-11 |
| 2023-03-31 | $3.15M 10-Q · filed 2024-05-09 | $4.83M derived: sum of 2 quarters · filed 2025-03-11 | $9.32M derived: sum of 3 quarters · filed 2025-03-11 | $13.99M derived: sum of 4 quarters · filed 2025-03-11 |
| 2022-12-31 | $1.68M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-11 | $6.17M derived: sum of 2 quarters · filed 2025-03-11 | $10.84M derived: sum of 3 quarters · filed 2025-03-11 | $14.88M 10-K · filed 2025-03-11 |
| 2022-09-30 | $4.49M derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-07 | $9.16M derived: sum of 2 quarters · filed 2023-11-07 | $13.20M 10-Q · filed 2023-11-07 | $17.56M derived: sum of 4 quarters · filed 2023-11-07 |
| 2022-06-30 | $4.66M derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-08 | $8.71M 10-Q · filed 2023-08-08 | $13.07M derived: sum of 3 quarters · filed 2023-08-08 | $17.39M derived: sum of 4 quarters · filed 2023-08-08 |
| 2022-03-31 | $4.04M 10-Q · filed 2023-05-09 | $8.40M derived: sum of 2 quarters · filed 2023-05-09 | $12.72M derived: sum of 3 quarters · filed 2023-05-09 | $16.47M derived: sum of 4 quarters · filed 2023-05-09 |
| 2021-12-31 | $4.36M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-14 | $8.68M derived: sum of 2 quarters · filed 2023-03-14 | $12.42M derived: sum of 3 quarters · filed 2023-03-14 | $16.10M 10-K · filed 2023-03-14 |
| 2021-09-30 | $4.32M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-09 | $8.06M derived: sum of 2 quarters · filed 2022-11-09 | $11.74M 10-Q · filed 2022-11-09 | $15.83M derived: sum of 4 quarters · filed 2022-11-09 |
| 2021-06-30 | $3.74M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09 | $7.42M 10-Q · filed 2022-08-09 | $11.51M derived: sum of 3 quarters · filed 2022-08-09 | $15.87M derived: sum of 4 quarters · filed 2022-08-09 |
| 2021-03-31 | $3.68M 10-Q · filed 2022-05-09 | $7.77M derived: sum of 2 quarters · filed 2022-05-09 | $12.13M derived: sum of 3 quarters · filed 2022-05-09 | $15.76M derived: sum of 4 quarters · filed 2022-05-09 |
| 2020-12-31 | $4.09M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-08 | $8.45M derived: sum of 2 quarters · filed 2022-03-08 | $12.09M derived: sum of 3 quarters · filed 2022-03-08 | $14.45M 10-K · filed 2022-03-08 |
| 2020-09-30 | $4.36M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-09 | $7.99M derived: sum of 2 quarters · filed 2021-11-09 | $10.36M 10-Q · filed 2021-11-09 | $13.46M derived: sum of 4 quarters · filed 2022-03-08 |
| 2020-06-30 | $3.63M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-06 | $6.00M 10-Q · filed 2021-08-06 | $9.10M derived: sum of 3 quarters · filed 2022-03-08 | $12.13M derived: sum of 4 quarters · filed 2022-03-08 |
| 2020-03-31 | $2.37M 10-Q · filed 2021-05-07 | $5.47M derived: sum of 2 quarters · filed 2022-03-08 | $8.50M derived: sum of 3 quarters · filed 2022-03-08 | $11.49M derived: sum of 4 quarters · filed 2022-03-08 |
| 2019-12-31 | $3.10M derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-08 | $6.13M derived: sum of 2 quarters · filed 2022-03-08 | $9.12M derived: sum of 3 quarters · filed 2022-03-08 | $11.39M 10-K · filed 2022-03-08 |
| 2019-09-30 | $3.03M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-09 | $6.02M derived: sum of 2 quarters · filed 2020-11-09 | $8.29M 10-Q · filed 2020-11-09 | $13.26M derived: sum of 4 quarters · filed 2021-02-25 |
| 2019-06-30 | $2.99M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-07 | $5.26M 10-Q · filed 2020-08-07 | $10.23M derived: sum of 3 quarters · filed 2021-02-25 | $12.53M derived: sum of 4 quarters · filed 2021-02-25 |
| 2019-03-31 | $2.27M 10-Q · filed 2020-05-11 | $7.24M derived: sum of 2 quarters · filed 2021-02-25 | $9.54M derived: sum of 3 quarters · filed 2021-02-25 | $11.55M derived: sum of 4 quarters · filed 2021-02-25 |
| 2018-12-31 | $4.97M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-25 | $7.27M derived: sum of 2 quarters · filed 2021-02-25 | $9.28M derived: sum of 3 quarters · filed 2021-02-25 | $11.02M 10-K · filed 2021-02-25 |
| 2018-09-30 | $2.30M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-08 | $4.31M derived: sum of 2 quarters · filed 2019-11-08 | $6.06M 10-Q · filed 2019-11-08 | $8.05M derived: sum of 4 quarters · filed 2020-02-27 |
| 2018-06-30 | $2.01M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-07 | $3.75M 10-Q · filed 2019-08-07 | $5.75M derived: sum of 3 quarters · filed 2020-02-27 | $8.07M derived: sum of 4 quarters · filed 2020-02-27 |
| 2018-03-31 | $1.75M 10-Q · filed 2019-05-07 | $3.74M derived: sum of 2 quarters · filed 2020-02-27 | $6.06M derived: sum of 3 quarters · filed 2020-02-27 | $8.39M derived: sum of 4 quarters · filed 2020-02-27 |
| 2017-12-31 | $2.00M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-27 | $4.32M derived: sum of 2 quarters · filed 2020-02-27 | $6.65M derived: sum of 3 quarters · filed 2020-02-27 | $9.09M 10-K · filed 2020-02-27 |
| 2017-09-30 | $2.32M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-06 | $4.65M derived: sum of 2 quarters · filed 2018-11-06 | $7.10M 10-Q · filed 2018-11-06 | $9.92M derived: sum of 4 quarters · filed 2019-03-18 |
| 2017-06-30 | $2.33M derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-08 | $4.78M 10-Q · filed 2018-08-08 | $7.60M derived: sum of 3 quarters · filed 2019-03-18 | $11.19M derived: sum of 4 quarters · filed 2019-03-18 |
| 2017-03-31 | $2.45M 10-Q · filed 2018-05-08 | $5.27M derived: sum of 2 quarters · filed 2019-03-18 | $8.86M derived: sum of 3 quarters · filed 2019-03-18 | $12.59M derived: sum of 4 quarters · filed 2019-03-18 |
| 2016-12-31 | $2.83M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-18 | $6.41M derived: sum of 2 quarters · filed 2019-03-18 | $10.14M derived: sum of 3 quarters · filed 2019-03-18 | $13.86M 10-K · filed 2019-03-18 |
| 2016-09-30 | $3.59M derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-07 | $7.32M derived: sum of 2 quarters · filed 2017-11-07 | $11.03M 10-Q · filed 2017-11-07 | $15.01M derived: sum of 4 quarters · filed 2018-03-08 |
| 2016-06-30 | $3.73M derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-08 | $7.45M 10-Q · filed 2017-08-08 | $11.43M derived: sum of 3 quarters · filed 2018-03-08 | $15.57M derived: sum of 4 quarters · filed 2018-03-08 |
| 2016-03-31 | $3.72M 10-Q · filed 2017-05-09 | $7.70M derived: sum of 2 quarters · filed 2018-03-08 | $11.84M derived: sum of 3 quarters · filed 2018-03-08 | $16.48M derived: sum of 4 quarters · filed 2018-03-08 |
| 2015-12-31 | $3.98M derived: 10-K 12 month − 10-Q 9 month · filed 2018-03-08 | $8.12M derived: sum of 2 quarters · filed 2018-03-08 | $12.76M derived: sum of 3 quarters · filed 2018-03-08 | $16.83M 10-K · filed 2018-03-08 |
| 2015-09-30 | $4.14M derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-09 | $8.78M derived: sum of 2 quarters · filed 2016-11-09 | $12.85M 10-Q · filed 2016-11-09 | $18.51M derived: sum of 4 quarters · filed 2017-03-03 |
| 2015-06-30 | $4.64M derived: 10-Q 6 month − 10-Q 3 month · filed 2016-08-09 | $8.71M 10-Q · filed 2016-08-09 | $14.37M derived: sum of 3 quarters · filed 2017-03-03 | $20.39M derived: sum of 4 quarters · filed 2017-03-03 |
| 2015-03-31 | $4.07M 10-Q · filed 2016-05-09 | $9.73M derived: sum of 2 quarters · filed 2017-03-03 | $15.75M derived: sum of 3 quarters · filed 2017-03-03 | $21.63M derived: sum of 4 quarters · filed 2017-03-03 |
| 2014-12-31 | $5.66M derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-03 | $11.68M derived: sum of 2 quarters · filed 2017-03-03 | $17.56M derived: sum of 3 quarters · filed 2017-03-03 | $20.94M 10-K · filed 2017-03-03 |
| 2014-09-30 | $6.02M derived: 10-Q 9 month − 10-Q 6 month · filed 2015-11-09 | $11.90M derived: sum of 2 quarters · filed 2015-11-09 | $15.28M 10-Q · filed 2015-11-09 | $17.04M derived: sum of 4 quarters · filed 2016-02-29 |
| 2014-06-30 | $5.88M derived: 10-Q 6 month − 10-Q 3 month · filed 2015-08-10 | $9.26M 10-Q · filed 2015-08-10 | $11.01M derived: sum of 3 quarters · filed 2016-02-29 | $12.76M derived: sum of 4 quarters · filed 2016-02-29 |
| 2014-03-31 | $3.38M 10-Q · filed 2015-05-11 | $5.14M derived: sum of 2 quarters · filed 2016-02-29 | $6.88M derived: sum of 3 quarters · filed 2016-02-29 | $8.56M derived: sum of 4 quarters · filed 2016-02-29 |
| 2013-12-31 | $1.76M derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-29 | $3.51M derived: sum of 2 quarters · filed 2016-02-29 | $5.18M derived: sum of 3 quarters · filed 2016-02-29 | $6.44M 10-K · filed 2016-02-29 |
| 2013-09-30 | $1.75M derived: 10-Q 9 month − 10-Q 6 month · filed 2014-11-06 | $3.43M derived: sum of 2 quarters · filed 2014-11-06 | $4.68M 10-Q · filed 2014-11-06 | $5.72M derived: sum of 4 quarters · filed 2015-02-26 |
| 2013-06-30 | $1.68M derived: 10-Q 6 month − 10-Q 3 month · filed 2014-08-04 | $2.93M 10-Q · filed 2014-08-04 | $3.97M derived: sum of 3 quarters · filed 2015-02-26 | $5.01M derived: sum of 4 quarters · filed 2015-02-26 |
| 2013-03-31 | $1.25M 10-Q · filed 2014-05-12 | $2.30M derived: sum of 2 quarters · filed 2015-02-26 | $3.33M derived: sum of 3 quarters · filed 2015-02-26 | $4.41M derived: sum of 4 quarters · filed 2015-02-26 |
| 2012-12-31 | $1.04M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-26 | $2.07M derived: sum of 2 quarters · filed 2015-02-26 | $3.15M derived: sum of 3 quarters · filed 2015-02-26 | $4.09M 10-K · filed 2015-02-26 |
| 2012-09-30 | $1.03M derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-07 | $2.11M derived: sum of 2 quarters · filed 2013-11-07 | $3.05M 10-Q · filed 2013-11-07 | $3.85M derived: sum of 4 quarters · filed 2014-03-12 |
| 2012-06-30 | $1.08M derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-07 | $2.01M 10-Q · filed 2013-08-07 | $2.82M derived: sum of 3 quarters · filed 2014-03-12 | $3.48M derived: sum of 4 quarters · filed 2014-03-12 |
| 2012-03-31 | $935.00K 10-Q · filed 2013-05-09 | $1.74M derived: sum of 2 quarters · filed 2014-03-12 | $2.41M derived: sum of 3 quarters · filed 2014-03-12 | $2.94M derived: sum of 4 quarters · filed 2014-03-12 |
| 2011-12-31 | $805.00K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-12 | $1.47M derived: sum of 2 quarters · filed 2014-03-12 | $2.01M derived: sum of 3 quarters · filed 2014-03-12 | $2.80M 10-K · filed 2014-03-12 |
| 2011-09-30 | $666.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-09 | $1.20M derived: sum of 2 quarters · filed 2012-11-09 | $1.99M 10-Q · filed 2012-11-09 | $2.31M derived: sum of 4 quarters · filed 2013-03-12 |
| 2011-06-30 | $538.00K derived: 10-Q 6 month − 10-Q 3 month · filed 2012-08-14 | $1.33M 10-Q · filed 2012-08-14 | $1.65M derived: sum of 3 quarters · filed 2013-03-12 | $2.07M derived: sum of 4 quarters · filed 2013-03-12 |
| 2011-03-31 | $790.00K 10-Q · filed 2012-05-15 | $1.11M derived: sum of 2 quarters · filed 2013-03-12 | $1.53M derived: sum of 3 quarters · filed 2013-03-12 | |
| 2010-12-31 | $320.00K derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-12 | $740.00K derived: sum of 2 quarters · filed 2013-03-12 | $1.59M 10-K · filed 2013-03-12 | |
| 2010-09-30 | $420.00K derived: 10-Q 9 month − 10-Q 6 month · filed 2011-11-14 | $1.27M 10-Q · filed 2011-11-14 | ||
| 2010-06-30 | $846.00K 10-Q · filed 2011-08-09 | |||
| 2009-12-31 | $2.11M 10-K · filed 2012-03-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ROCKET PHARMACEUTICALS, INC. (RCKT) | United States | $0.296B | -21.78 |
| Vanda Pharmaceuticals Inc. (VNDA) | United States | $0.302B | -1.35 |
| Fulcrum Therapeutics, Inc. (FULC) | United States | $0.289B | -3.28 |
| Contineum Therapeutics, Inc. (CTNM) | United States | $0.289B | -4.40 |
| GT Biopharma, Inc. (GTBP) | United States | $0.309B | -4.58 |
| Perspective Therapeutics, Inc. (CATX) | United States | $0.284B | -3.34 |
| Upstream Bio, Inc. (UPB) | United States | $0.284B | -2.42 |
| ABEONA THERAPEUTICS INC. (ABEO) | United States | $0.312B | -5.63 |
| Sagimet Biosciences Inc. (SGMT) | United States | $0.279B | |
| Prelude Therapeutics Inc (PRLD) | United States | $0.318B | -7.01 |